Table 1 Characteristics of included patients (n = 91)

Age^a median and interval, in years

67 (38–90)

BMI^a median and interval in kg/m²

29.96 (19.23–53.83)

Menopause^a

82 (90.11 %)

Hormonal treatment for the menopause^a

26 (28.57 %)

Preoperative endometrial sample

 Curettage

44 (48.35 %)

 Pipelle

47 (51.64 %)

Surgery performed^a

 Total hysterectomy with BSO

87 (95.60 %)

 Total hysterectomy

4 (4.40 %)

Surgical approach^a

 Laparotomy

23 (25.27 %)

 Laparoscopy

64 (70.33 %)

 Vaginal

4 (4.40 %)

Lymphadenectomy^a

 No

37 (40.66 %)

 Pelvic

36 (39.56 %)

 Pelvic + sentinel lymph node

3 (3.30 %)

 Pelvic + para-aortic

13 (14.29 %)

 Sentinel lymph node

2 (2.20 %)

 FIGO stage (2009)^a

 IA

45 (49.45 %)

 IB

21 (23.08 %)

 II

13 (14.29 %)

 IIIA

2 (2.20 %)

 IIIB

1 (1.10 %)

 IIIIC

7 (7.69 %)

 IV

2 (2.20 %)

 Histological type^a

Type 1

78 (85.71 %)

  Grade 1

46 (50.55 %)

  Grade 2

20 (21.98 %)

  Grade 3

12 (13.19 %)

Type 2

11 (12.09 %)

 Absence of residual malignant cells

2 (2.20 %)

 Lymphovascular emboli^a

32 (35.16 %)

 Risk of recurrence^a

 Low

33 (36.26 %)

 Intermediate

14 (15.38 %)

 High

44 (48.35 %)